GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTC Bio Inc (XKRX:060590) » Definitions » Debt-to-Revenue

CTC Bio (XKRX:060590) Debt-to-Revenue : 0.27 (As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is CTC Bio Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

CTC Bio's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩32,071 Mil. CTC Bio's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩3,719 Mil. CTC Bio's annualized Revenue for the quarter that ended in Mar. 2024 was ₩132,772 Mil. CTC Bio's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.27.


CTC Bio Debt-to-Revenue Historical Data

The historical data trend for CTC Bio's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTC Bio Debt-to-Revenue Chart

CTC Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.41 0.26 0.24 0.26

CTC Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.25 0.30 0.25 0.27

Competitive Comparison of CTC Bio's Debt-to-Revenue

For the Biotechnology subindustry, CTC Bio's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CTC Bio's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CTC Bio's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where CTC Bio's Debt-to-Revenue falls into.



CTC Bio Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

CTC Bio's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(31512.634 + 3776.14) / 137878.037
=0.26

CTC Bio's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(32070.642 + 3719.282) / 132771.912
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


CTC Bio Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of CTC Bio's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CTC Bio (XKRX:060590) Business Description

Traded in Other Exchanges
N/A
Address
94, Saengmyeonggwahakgwan-gil, Gangwon-do, Hongcheon, KOR, 25142
CTC Bio Inc is engaged in the manufacturing and distribution of pharmaceutical products, veterinary medicines, feed additives, feed ingredients, and functional foods.

CTC Bio (XKRX:060590) Headlines

No Headlines